Please provide your email address to receive an email when new articles are posted on . Two clinical trials have demonstrated positive results for the full range of vision IOL. Bausch + Lomb ...

Please provide your email address to receive an email when new articles are posted on . Bausch + Lomb expects the enVista Envy IOL to be commercially available in Canada in mid-June. The company is ...

Bausch + Lomb (NYSE:BLCO) received US FDA clearance for its Bi-Blade+ dual-port vitrectomy cutter and Adaptive Fluidics update, expanding its retina surgery toolkit. The company launched the enVista ...

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced European commercial availability of the preloaded ...

VAUGHAN, Ontario--(BUSINESS WIRE)-- Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that the U.S.

enVista Envy full range of vision intraocular lens (IOL) met all primary efficacy and safety endpoints in multicenter study Results show that enVista Envy IOLs deliver excellent visual performance, ...

Bausch + Lomb's received approval from the Food and Drug Administration for enVista Envy's full range of vision intraocular lens. The Canadian eye-health company said enVista offers a continuous range ...

Bausch + Lomb, a leading global eye health company, announced a voluntary recall of its Envista Aspire, Envista Envy and certain Envistar intraocular lens injector systems, according to the Food and ...

Add Yahoo as a preferred source to see more of our stories on Google. Bausch + Lomb has recalled lenses used during cataract surgery due to complications when the lenses are used, according to an ...